Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to ...
The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price ...
Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...
We’re firmly in the “buyer beware” era of obesity drugs. And unfortunately, it seems like we’re going to be stuck here for a ...
A pill Novo acquired produced modest weight loss but raised safety questions. Elsewhere, Sanofi detailed the silver lining it found in a recent study and a heart drug developer’s shares surged.
Discounts of as much as half on the $1,000-plus-a-month injectables are meant to induce insurers to offer coverage to workers ...
Half a century of advancements in biomedical science paved the way for today’s powerful weight-loss drugs like Ozempic — so ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
WITH all the buzz around the so-called ‘miracle’ weight-loss jabs Ozempic, you could easily mistake it for a cure for all.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback